NFKB1 and chronic obstructive pulmonary disease: As shown in Figure 3A‒E, silencing NRF1 significantly inhibited p65 expression cells treated with LPS, CSE, PAM3CSK4, or their combinations, suggesting that upregulation of NRF1 in COPD progress is associated with NF-κB signaling activation.